Cisema at 2026 CIFIT Hong Kong Pavilion: Pharmaceutical & Medical Device Regulation in Hong Kong & Southeast Asia
At the 2026 China International Fair for Investment and Trade (CIFIT) in Xiamen, Cisema Vice President Jacky Li took the stage at the Hong Kong Pavilion as an invited speaker by the Hong Kong Trade Development Council (HKTDC). Speaking to an audience of industry leaders and trade delegates, he highlighted the regulatory pathways connecting Hong Kong with expanding pharmaceutical and medical device markets across Southeast Asia.
About the 2026 CIFIT Hong Kong Pavilion
Designed to help mainland enterprises scale internationally, the 2026 CIFIT Hong Kong Pavilion Expert Thematic Sharing and Matchmaking Meeting brought together key business leaders and professional service providers. The session, hosted in Xiamen by the Ministry of Commerce during the 26th CIFIT (September 8–11, 2026), offered practical perspectives on cross-border business strategies and regional market opportunities.
Central to this international push is Hong Kong’s robust professional ecosystem, spanning financial, legal, accounting, and consulting disciplines. Beyond traditional services, Hong Kong's specialized regulatory and compliance expertise serves as a vital bridge for companies navigating complex market entry requirements across Asia.
Cisema Presentation
Topic: Seizing Opportunities in Hong Kong’s Pharmaceutical and Medical Device Regulation: A Regional Perspective and Outlook for Southeast Asia
As pharmaceutical and medical device companies increasingly pursue growth across multiple Asian markets, understanding how regulatory requirements differ between jurisdictions is an important part of regional expansion planning.
Hong Kong can serve as an important connection point for companies looking beyond a single market. However, expanding into Southeast Asia still requires an understanding of each country's regulatory framework, registration or notification requirements, local representation obligations and ongoing compliance expectations.
Jacky’s presentation unpacked how to unify these moving parts into a single, cohesive regional strategy.
Attendees gained insights into:
- Pharmaceutical and medical device regulatory considerations across Hong Kong and Southeast Asia
- The role of Hong Kong within a broader regional market-access strategy
- Regulatory differences between Asian markets
- Key considerations when expanding pharmaceutical and medical device products across Southeast Asia
- Building a coordinated regulatory approach for multi-market expansion
Presentation Details
Date: September 9, 2026
Time: 3:00–4:00 pm
Location: Hong Kong Pavilion, Hall 3, Unit 3-160, Xiamen International Expo & Exhibition Center
Speaker: Jacky Li, Vice President Hong Kong, Macao & GBA, Cisema (Hong Kong) Limited
Further Information
Explore Cisema's pharmaceutical and medical device regulatory services across Asia Pacific:
- Discover Cisema’s pharmaceutical regulatory consulting services.
- Learn more about Cisema’s medical device services in Hong Kong and mainland China.
- Explore our medical device services across Southeast Asia: Malaysia | Vietnam | Singapore | Thailand | Indonesia | Philippines